GROWTH BUYOUT & VENTURE CAPITAL

Engaged Partnership - A long-term view.
The essentials for transformative growth in life sciences.

 


Latest Investment

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. The Company’s lead program, ADP101, is being

News

2020-04-21

Zikani Therapeutics Completes Series A-1 Funding Company Poised to Advance its TURBO-ZM™ Technology Platform to Develop Novel Ribosome Modulators to Treat Rare Nonsense Mutations